Antecedents and outcomes of a later attention–deficit hyperactivity disorder (ADHD) diagnosis in females
The British Journal of Psychiatry · 10.03.2026 · 1-8
DOI: 10.1192/bjp.2026.10556 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 10.03.2026. Verfasst von Joanna Martin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuropsychiatric Genetics and Genomics, https://ror.org/03kk7td41Cardiff University, UK. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HCRW_.
Abstract (Originalsprache)
Background
Females are less likely than males to be diagnosed with attention–deficit hyperactivity disorder (ADHD). When diagnosed, females are older than males.
Aims
In this study, we examined the childhood antecedents of later ADHD diagnosis and its impact on adolescent/emerging adult outcomes, with a focus on females.
Method
In this cohort study, we used data from a Welsh nation-wide electronic cohort of 13 593 individuals ( n = 2680 (19.7%) females) diagnosed with ADHD and 578 793 individuals ( n = 286 734 (49.5%) females) without ADHD. We compared females with later diagnoses (ages 12–25) to those with earlier, timely diagnoses (ages 5–11) and no diagnosis, in terms of childhood (ages 5–11) antecedents and adolescent/adult (ages 12–25) outcomes. We also tested for sex differences.
Results
Although females with earlier ADHD diagnosis showed more health and educational difficulties in childhood than those with later diagnosed ADHD (odds ratios ranged from 0.18 to 0.92), there was clear evidence of these difficulties in females with later diagnosed ADHD, compared with females without ADHD (odds ratios: 1.07–9.02). In adolescence/early adulthood, females with later diagnosed ADHD used more healthcare services and had worse mental health, educational and socioeconomic outcomes than females diagnosed earlier (odds ratios: 1.39–4.96) and those without ADHD (odds ratios: 1.54–23.98). Many of these outcomes were exacerbated in females compared with males.
Conclusions
The results demonstrate that later ADHD diagnosis is associated with significant negative outcomes by adolescence and disproportionately disadvantages females. Despite later diagnosis, there was clear evidence of childhood mental health and educational difficulties when compared with females without ADHD. Therefore, timely childhood ADHD diagnosis may help to mitigate later risks, especially for females.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Neuropsychiatric Genetics and Genomics, https://ror.org/03kk7td41Cardiff University, UK.
- Wolfson Centre for Young People's Mental Health, Cardiff University, UK.
- Institute of Suicide Prevention and Mental Health, Swansea University, UK.
- GESIS, Leibniz Institutes for the Social Sciences, Cologne, Germany.
- School of Psychology, Cardiff University, UK.
- Clinical Partners Limited, Semley, UK.
ORCID-Profile: Joanna Martin, Kapil Sayal, Tamsin J Ford, Ann John
Förderung
- HCRW_
Zitieren
APA
Martin, J., Rouquette, O. Y., Langley, K., Cooper, M., Sayal, K., Ford, T. J., John, A., & Thapar, A. (2026). Antecedents and outcomes of a later attention–deficit hyperactivity disorder (ADHD) diagnosis in females. The British Journal of Psychiatry, 1-8. https://doi.org/10.1192/bjp.2026.10556
Vancouver
Martin J, Rouquette OY, Langley K, Cooper M, Sayal K, Ford TJ, et al. Antecedents and outcomes of a later attention–deficit hyperactivity disorder (ADHD) diagnosis in females. The British Journal of Psychiatry. 2026:1-8. doi:10.1192/bjp.2026.10556
BibTeX
@article{Martin2026,
author = {Martin, Joanna and Rouquette, Olivier Y and Langley, Kate and Cooper, Miriam and Sayal, Kapil and Ford, Tamsin J and John, Ann and Thapar, Anita},
title = {Antecedents and outcomes of a later attention–deficit hyperactivity disorder (ADHD) diagnosis in females},
journal = {The British Journal of Psychiatry},
year = {2026},
pages = {1--8},
doi = {10.1192/bjp.2026.10556}
}
EUVIMED